Evidence map›Paper›PMID 25229475›Full record

ArticlePloS one2014

Effect of oral administration of metronidazole or prednisolone on fecal microbiota in dogs.

Hirotaka Igarashi, Shingo Maeda, Koichi Ohno, Ayako Horigome, Toshitaka Odamaki, Hajime Tsujimoto

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 148 citations in OpenAlex.

  1. Article
  2. Article
  3. An Ecological Framework for Interpreting the Canine Gut Microbiome.Animals : an open access journal from MDPI · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Frontiers in veterinary science · 2025
    Article
  13. Impact ofFrontiers in veterinary science · 2025
    Article
  14. Article
  15. Article
  16. Regulation Effect ofMicroorganisms · 2024
    Article
  17. Review
  18. Article
  19. Article
  20. Updating the Classification of Chronic Inflammatory Enteropathies in Dogs.Animals : an open access journal from MDPI · 2024
    Review

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Hirotaka IgarashiDepartment of Veterinary Internal Medicine, Graduate School of Agricultural and Life Science, The University of Tokyo, Tokyo, Japan.
Shingo MaedaDepartment of Veterinary Internal Medicine, Graduate School of Agricultural and Life Science, The University of Tokyo, Tokyo, Japan.
Koichi OhnoDepartment of Veterinary Internal Medicine, Graduate School of Agricultural and Life Science, The University of Tokyo, Tokyo, Japan.
Ayako HorigomeFood Science and Technology Institute, Morinaga Milk Industry Co. Ltd., Kanagawa, Japan.
Toshitaka OdamakiFood Science and Technology Institute, Morinaga Milk Industry Co. Ltd., Kanagawa, Japan.
Hajime TsujimotoDepartment of Veterinary Internal Medicine, Graduate School of Agricultural and Life Science, The University of Tokyo, Tokyo, Japan.
The University of Tokyo · JPMegmilk Snow Brand (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastrointestinal microbiota have been implicated in the pathogenesis of various gastrointestinal disorders in dogs, including acute diarrhea and chronic enteropathy. Metronidazole and prednisolone are commonly prescribed for the treatment of these diseases; however, their effects on gastrointestinal microbiota have not been investigated. The objective of this study was to evaluate the effects of these drugs on the gastrointestinal microbiota of dogs. Metronidazole was administered twice daily at 12.5 mg/kg to a group of five healthy dogs, and prednisolone at 1.0 mg/kg daily to a second group of five healthy dogs for 14 days. Fecal samples were collected before and after administration (day 0 and 14), and 14 and 28 days after cessation (day 28 and 42). DNA was extracted, and the bacterial diversity and composition of each sample were determined based on 16S ribosomal RNA (rRNA) gene sequences using next-generation sequencing (Illumina MiSeq). In the group administered metronidazole, bacterial diversity indices significantly decreased at day 14, and recovered after the cessation. Principal coordinates analysis and hierarchical dendrogram construction based on unweighted and weighted UniFrac distance matrices revealed that bacterial composition was also significantly altered by metronidazole at day 14 compared with the other time points. The proportions of Bacteroidaceae, Clostridiaceae, Fusobacteriaceae, Lachnospiraceae, Ruminococcaceae, Turicibacteraceae, and Veillonellaceae decreased, while Bifidobacteriaceae, Enterobacteriaceae, Enterococcaceae, and Streptococcaceae increased at day 14 and returned to their initial proportions by day 42. Conversely, no effect of prednisolone was observed on either the bacterial diversity or composition. Reducing pathogenic bacteria such as Fusobacteria and increasing beneficial bacteria such as Bifidobacterium through the administration of metronidazole may be beneficial for promoting gastrointestinal health; however, further investigations into the effects on diseased dogs are needed.

Indexed as

Administration, OralAnimalsBacteriaBiodiversityDogsFecesFemaleMaleMetronidazoleMicrobiotaPrednisoloneRNA, Ribosomal, 16SSequence Analysis, RNAMetronidazolePrednisoloneRNA, Ribosomal, 16S

Identifiers

PMID25229475
PMCPMC4168260
OpenAlexW2087223690

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.